AngioDynamics Director Eileen O'Shea Receives RSU Award

What Happened Eileen O'Shea Auen, a director of AngioDynamics, Inc. (ANGO), was granted 11,887 restricted stock units (RSUs) on 2026-07-15 as her regular annual director compensation. The Form 4 reports the acquisition at $0.00 per share (total $0) and notes the RSUs immediately vested at grant.

Key Details

• Transaction date: 2026-07-15; Form 4 filed: 2026-07-22 (appears later than the usual Section 16 reporting window).
• Transaction type: Award/Grant (code A); 11,887 RSUs granted and vested immediately.
• Price reported: $0.00 per share on the Form 4 (typical for equity awards recorded as grants).
• Shares owned after transaction: not specified in this filing.
• Footnote: F1 confirms these were annual director RSUs and that they vested immediately at grant.

Context This was a compensation grant to a non-employee director, not an open-market purchase or sale. Grants and immediately-vested RSUs are common forms of director compensation and do not by themselves indicate a buy/sell market signal. The filing date is 7 days after the transaction date; under Section 16 rules insiders generally must file within 2 business days, so the filing appears late.